Organigram Trailblazer Torch Vape Cartridges Among First ‘Cannabis 2.0’ Products Company Distributes to Market
December 23 2019 - 6:00AM
Business Wire
First wave of Company’s vaporizer offerings
shipped in accordance with allowable timelines
Organigram Holdings Inc. (NASDAQ:OGI) (TSX:OGI), the parent
company of Organigram Inc. (the “Company” or “Organigram”), a
leading licensed producer of cannabis, is pleased to announce the
first of its ‘Cannabis 2.0’ products have been released, including
Trailblazer Spark, Flicker and Glow 510-thread Torch vape
cartridges.
Shipments of the custom-designed cartridges were sent to
Manitoba, Saskatchewan, Ontario, New Brunswick and Nova Scotia,
starting December 17, from the Company’s Moncton production
campus.
The first release from Organigram’s suite of vaporizer offerings
affirms the Company’s commitment to supporting Canadians’ access to
a variety of regulated recreational cannabis products.
“As a company, bringing the next-generation of cannabis products
to market without delay was important to us. We are proud to
support access to tested, quality derivative-based products that we
expect to help strengthen the regulated market and benefit those
who prefer those product types over others,” said Greg Engel, CEO,
Organigram. “Being one of the first licensed producers in the
country ready to provide vape products, following the expiration of
Health Canada’s 60-day notification period, illustrates that degree
of focus and commitment. It speaks to an extraordinary effort by
our internal teams who helped bring the Trailblazer Torch to
market.”
The cartridges, filled with C0₂-extracted cannabis concentrate
oil and botanical terpenes, are custom-engineered with borosilicate
glass and stainless-steel components, designed to accommodate a
standard 510-thead battery. With three distinct offerings, Spark
(sativa-dominant), Flicker (hybrid) and Glow (indica-dominant),
inspired by dried flower and pre-roll products under the Company’s
Trailblazer-branded product lineup.
The release is the first of the Company’s planned and staggered
rollout of vaporizable products, including Edison + Feather
ready-to-go distillate pens and Edison + PAX ERA® distillate
cartridges. Launches of both products are set to occur in markets
across Canada through January. Certain provinces have announced
delays or other restrictions on the launch of vaporizable products
in their markets including Newfoundland & Labrador, Quebec and
Alberta and the Company is adjusting its distribution schedules
accordingly.
The Company’s next-generation product portfolio includes
high-quality infused chocolate and a dissolvable powdered beverage
product, designed using nanotechnology for faster onset of
cannabinoids (when compared to traditional edible products).
Planned releases of Organigram’s edible products are anticipated
through calendar Q1 and Q2 of 2020.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Ankr Organics and Trailblazer.
Organigram's primary facility is located in Moncton, New Brunswick
and the Company is regulated by the Cannabis Act and the Cannabis
Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
factors that could change anticipated timelines for product
launches; including risks as disclosed in the Company’s most recent
annual information form, management’s discussion and analysis and
other Company documents filed from time to time on SEDAR (see
www.sedar.com) and filed or furnished to the Securities and
Exchange Commission on EDGAR (see www.sec.gov). Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
Although the Company believes that the assumptions and factors used
in preparing the forward-looking information in this news release
are reasonable, undue reliance should not be placed on such
information and no assurance can be given that such events will
occur in the disclosed time frames or at all. The forward-looking
information included in this news release are made as of the date
of this news release and the Company disclaims any intention or
obligation, except to the extent required by law, to update or
revise any forward-looking information, whether as a result of new
information, future events or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191223005117/en/
For Investor Relations enquiries: Amy Schwalm Vice President,
Investor Relations Amy.Schwalm@organigram.ca (416) 704-9057
For Media enquiries: Ray Gracewood Senior Vice President,
Marketing and Communications ray.gracewood@organigram.ca (506)
645-1653
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Sep 2023 to Sep 2024